Working… Menu

Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00248703
Recruitment Status : Active, not recruiting
First Posted : November 4, 2005
Last Update Posted : March 8, 2021
University of Tromso
Helse Stavanger HF
Sorlandet Hospital HF
Sykehuset Innlandet HF
Ullevaal University Hospital
Sykehuset i Vestfold HF
Sykehuset Ostfold
Alesund Hospital
Information provided by (Responsible Party):
Bjørn Naume, Oslo University Hospital